Lifecore Biomedical, Inc. (LFCR) stock
LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
$6.42+0.02 (+0.31%)
Close on Nov 13, 2026Market cap $243.02MP/E –Yield –
Lifecore Biomedical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Lifecore Biomedical's profit margin for the twelve months ending May 25, 2025 was -30.0%. For fiscal 2025 it was -30.0%, against 9.4% the year before. The highest annual figure on record is 9.4% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | May 25, 2025 | -30.0% | −39.4 |
| FY2024 | May 26, 2024 | 9.4% | +105.8 |
| FY2023 | May 28, 2023 | -96.4% | +8.5 |
| FY2022 | May 29, 2022 | -104.9% | −72.9 |
| FY2021 | May 30, 2021 | -32.0% | −8.2 |
| FY2020 | May 31, 2020 | -23.9% | −23.9 |
| FY2019 | May 26, 2019 | 0.1% | −4.7 |
| FY2018 | May 27, 2018 | 4.7% | +2.5 |
| FY2017 | May 28, 2017 | 2.3% | +4.7 |
| FY2016 | May 29, 2016 | -2.4% | −5.0 |
| FY2015 | May 31, 2015 | 2.5% | −1.5 |
| FY2014 | May 25, 2014 | 4.0% | −1.1 |
| FY2013 | May 26, 2013 | 5.1% | +1.1 |
| FY2012 | May 27, 2012 | 4.0% | +2.6 |
| FY2011 | May 29, 2011 | 1.4% | −0.3 |
| FY2010 | May 30, 2010 | 1.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2027CQ1 2026 | Sep 30, 2026 | -158.3% | −92.6 |
| Q4 FY2025CQ2 2025 | May 25, 2025 | -3.1% | +15.5 |
| Q3 FY2025CQ1 2025 | Feb 23, 2025 | -42.0% | −85.8 |
| Q2 FY2025CQ4 2024 | Nov 24, 2024 | -20.2% | −67.3 |
| Q1 FY2025CQ3 2024 | Aug 25, 2024 | -65.7% | −21.8 |
| Q4 FY2024CQ2 2024 | May 26, 2024 | -18.7% | +107.4 |
| Q3 FY2024CQ1 2024 | Feb 25, 2024 | 43.8% | +181.4 |
| Q2 FY2024CQ4 2023 | Nov 26, 2023 | 47.2% | +105.7 |
| Q1 FY2024CQ3 2023 | Aug 27, 2023 | -43.9% | +2.4 |
| Q4 FY2023CQ2 2023 | May 28, 2023 | -126.1% | +70.5 |
| Q3 FY2023CQ1 2023 | Feb 26, 2023 | -137.6% | −99.0 |
| Q2 FY2023CQ4 2022 | Nov 27, 2022 | -58.6% | +91.7 |
| Q1 FY2023CQ3 2022 | Aug 28, 2022 | -46.2% | −4.2 |
| Q4 FY2022CQ2 2022 | May 29, 2022 | -196.6% | −193.8 |
| Q3 FY2022CQ1 2022 | Feb 27, 2022 | -38.6% | −13.5 |
| Q2 FY2022CQ4 2021 | Nov 28, 2021 | -150.3% | −101.4 |
| Q1 FY2022CQ3 2021 | Aug 29, 2021 | -42.0% | +12.7 |
| Q4 FY2021CQ2 2021 | May 30, 2021 | -2.9% | +6.8 |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | -25.1% | −17.6 |
| Q2 FY2021CQ4 2020 | Nov 29, 2020 | -48.9% | −44.1 |
| Q1 FY2021CQ3 2020 | Aug 30, 2020 | -54.7% | −51.3 |
| Q4 FY2020CQ2 2020 | May 31, 2020 | -9.7% | −9.5 |
| Q3 FY2020CQ1 2020 | Feb 23, 2020 | -7.5% | −8.2 |
| Q2 FY2020CQ4 2019 | Nov 24, 2019 | -4.7% | −4.3 |
| Q1 FY2020CQ3 2019 | Aug 25, 2019 | -3.4% | −3.6 |
| Q4 FY2019CQ2 2019 | May 26, 2019 | -0.2% | −4.5 |
| Q3 FY2019CQ1 2019 | Feb 24, 2019 | 0.7% | −10.4 |
| Q2 FY2019CQ4 2018 | Nov 25, 2018 | -0.5% | −0.9 |
| Q1 FY2019CQ3 2018 | Aug 26, 2018 | 0.2% | −1.7 |
| Q4 FY2018CQ2 2018 | May 27, 2018 | 4.3% | +2.3 |
| Q3 FY2018CQ1 2018 | Feb 25, 2018 | 11.1% | +8.4 |
| Q2 FY2018CQ4 2017 | Nov 26, 2017 | 0.4% | −0.8 |
| Q1 FY2018CQ3 2017 | Aug 27, 2017 | 1.9% | −1.2 |
| Q4 FY2017CQ2 2017 | May 28, 2017 | 2.0% | −1.5 |
| Q3 FY2017CQ1 2017 | Feb 26, 2017 | 2.7% | – |
| Q2 FY2017CQ4 2016 | Nov 27, 2016 | 1.2% | – |
| Q1 FY2017CQ3 2016 | Aug 28, 2016 | 3.0% | – |
| Q4 FY2016CQ2 2016 | May 29, 2016 | 3.5% | – |
See a number that looks wrong?